Sun Pharmaceutical Industries LimitedNSE: SUNPHARMA

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 23, 2026.

· Issued by Sun Pharmaceutical Industries Limited via NSE India

Filed with NSE · ISIN INE044A01028 · · 7 pages · English

Summary by 6ix AI

Sun Pharmaceutical Industries Limited has issued a press release regarding its presentation at the ESMO Congress, detailing long-term follow-up data on UNLOXCYT for advanced cutaneous squamous cell carcinoma. The data highlights the efficacy and safety of UNLOXCYT, indicating a significant number of patients achieved a complete response. This filing serves to inform stakeholders about the upcoming presentation and the significance of the findings related to their treatment options.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Sun Pharmaceutical Industries Limited on 6ix

Story so far

Earlier from Sun Pharmaceutical Industries

Later from Sun Pharmaceutical Industries

All Sun Pharmaceutical Industries news releases